188 related articles for article (PubMed ID: 7938309)
1. [The baseline EEG traits and the induced EEG changes by chronic antidepressant medication in patients with major depression. Early prediction of clinical outcomes solely based on quantification and mapping of EEG].
Ohashi Y
Seishin Shinkeigaku Zasshi; 1994; 96(6):444-60. PubMed ID: 7938309
[TBL] [Abstract][Full Text] [Related]
2. [Analytic study on EEG features of aging with/without psychiatric disorders: focussing at the alterations in the EEGs of the healthy, depressive and demented elderlies].
Saito N
Seishin Shinkeigaku Zasshi; 1995; 97(10):801-24. PubMed ID: 8552725
[TBL] [Abstract][Full Text] [Related]
3. [Quantitative EEG characteristics of the state of depressive phase and the state of remission in major depression].
Suzuki H; Mori T; Kimura M; Endo S
Seishin Shinkeigaku Zasshi; 1996; 98(6):363-77. PubMed ID: 8810860
[TBL] [Abstract][Full Text] [Related]
4. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
[TBL] [Abstract][Full Text] [Related]
5. Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study.
Bares M; Brunovsky M; Kopecek M; Stopkova P; Novak T; Kozeny J; Höschl C
J Psychiatr Res; 2007; 41(3-4):319-25. PubMed ID: 16889798
[TBL] [Abstract][Full Text] [Related]
6. [A quantitative pharmaco-EEG study on psychotropic properties of cerebral metabolic enhancers: comparison between young and elderly healthy volunteers].
Nobuhara K
Seishin Shinkeigaku Zasshi; 1993; 95(5):392-416. PubMed ID: 8356168
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
Fawcett J; Barkin RL
J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
[TBL] [Abstract][Full Text] [Related]
8. Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression.
Hsiao CC
Psychoneuroendocrinology; 2006 Aug; 31(7):839-46. PubMed ID: 16716529
[TBL] [Abstract][Full Text] [Related]
9. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry.
Arnold O; Saletu B; Anderer P; Assandri A; di Padova C; Corrado M; Saletu-Zyhlarz GM
Eur Neuropsychopharmacol; 2005 Oct; 15(5):533-43. PubMed ID: 16046102
[TBL] [Abstract][Full Text] [Related]
11. [A computer-assisted EEG study on psychotropic properties of antiparkinsonian drugs].
Suitsu N
Seishin Shinkeigaku Zasshi; 1992; 94(3):238-62. PubMed ID: 1589555
[TBL] [Abstract][Full Text] [Related]
12. Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation.
Saletu B; Barbanoj MJ; Anderer P; Sieghart W; Grünberger J
Methods Find Exp Clin Pharmacol; 1993 Jun; 15(5):291-312. PubMed ID: 8412414
[TBL] [Abstract][Full Text] [Related]
13. [Topographic-quantitative EEG-analysis of the paradoxical arousal reaction. EEG changes during urologic surgery using isoflurane/ N2O anesthesia].
Bischoff P; Kochs E; Droese D; Meyer-Moldenhauer WH; Schulte am Esch J
Anaesthesist; 1993 Mar; 42(3):142-8. PubMed ID: 8480900
[TBL] [Abstract][Full Text] [Related]
14. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
Alpert JE; Franznick DA; Hollander SB; Fava M
J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
[TBL] [Abstract][Full Text] [Related]
15. EEG mapping in patients with social phobia.
Sachs G; Anderer P; Dantendorfer K; Saletu B
Psychiatry Res; 2004 Sep; 131(3):237-47. PubMed ID: 15465293
[TBL] [Abstract][Full Text] [Related]
16. Depressive psychosis: clinical usefulness of MR spectroscopy data in predicting prognosis.
Kado H; Kimura H; Murata T; Nagata K; Kanno I
Radiology; 2006 Jan; 238(1):248-55. PubMed ID: 16373773
[TBL] [Abstract][Full Text] [Related]
17. [Electroencephalography in psychiatry--current status and outlook].
Herrmann WM; Winterer G
Nervenarzt; 1996 May; 67(5):348-59. PubMed ID: 9005343
[TBL] [Abstract][Full Text] [Related]
18. [Studies of the correlations between morphological brain changes on MRI and computerized EEG changes in schizophrenics].
Takeuchi K
Seishin Shinkeigaku Zasshi; 1992; 94(6):584-604. PubMed ID: 1523274
[TBL] [Abstract][Full Text] [Related]
19. EEG power spectra at early stages of depressive disorders.
Grin-Yatsenko VA; Baas I; Ponomarev VA; Kropotov JD
J Clin Neurophysiol; 2009 Dec; 26(6):401-6. PubMed ID: 19952564
[TBL] [Abstract][Full Text] [Related]
20. All-night EEG spectral analysis as a tool for the prediction of clinical response to antidepressant treatment.
Luthringer R; Minot R; Toussaint M; Calvi-Gries F; Schaltenbrand N; Macher JP
Biol Psychiatry; 1995 Jul; 38(2):98-104. PubMed ID: 7578656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
